Equities

SIGA Technologies Inc

SIGA:NMQ

SIGA Technologies Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)7.06
  • Today's Change-0.48 / -6.37%
  • Shares traded444.20k
  • 1 Year change+43.20%
  • Beta0.9058
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year SIGA Technologies Inc grew revenues 26.31% from 110.78m to 139.92m while net income improved 100.76% from 33.90m to 68.07m.
Gross margin82.00%
Net profit margin48.55%
Operating margin59.39%
Return on assets49.52%
Return on equity57.59%
Return on investment56.21%
More ▼

Cash flow in USDView more

In 2023, SIGA Technologies Inc increased its cash reserves by 51.98%, or 51.36m. The company earned 94.80m from its operations for a Cash Flow Margin of 67.75%. In addition the company used 21.69k on investing activities and also paid 43.42m in financing cash flows.
Cash flow per share1.18
Price/Cash flow per share6.37
Book value per share2.35
Tangible book value per share2.34
More ▼

Balance sheet in USDView more

SIGA Technologies Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio8.25
Quick ratio5.65
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.